TABLE 2.
Characterization of plasmids from CMRSA isolates in Australiaa
| Strain | CC | Plasmid size (kb) | Phenotype | EcoRI fragment size(s) (kb) |
|---|---|---|---|---|
| WBG8287 | 1 | 19.6 | Bla, C | 14.6, 4.0, 1.0 |
| 2.0 | EI | ND | ||
| WBG8873 | 1 | 19.6 | Bla, C | 14.6, 4.0, 1.0 |
| 2.0 | EI | ND | ||
| WBG10200 | 1 | 19.6 | NA | 14.6, 4.0, 1.0 |
| WBG8900 | 78 | 19.6 | Bla, C | 14.6, 4.0, 1.0 |
| WBG8404 | 45 | 24.5 | Bla, C, As | 10.2, 5.0, 4.3, 3.6, 1.4 |
| WBG9087 | 75 | 25.6 | Bla, C | 23.0, 2.6 |
| WBG9093 | 75 | 19.6 | Bla, C | 14.6, 4.0, 1.0 |
| WBG7583 | 8 | 28.6 | Bla, C | 11.5, 10.3, 2.6, 2.3, 1.9 |
| WBG8320 | 8 | 32.1 | Bla, C, T | 14.3, 11.0, 2.6, 2.3, 1.9 |
| WBG7569 | 8 | 41.4 | Bla, C, T, Mup, Tp | 14.3, 11.5, 3.7, 3.0, 2.6, 2.3, 2.1, 1.9 |
| WBG10198 | 30 | 36 | NA | 20.0, 11.0, 3.2, 1.2, 0.6 |
| WBG10201 | 30 | 32.0 | NA | 19, 13.0 |
| WSPP-1b | 30 | 25.0 | NA | 17.3, 5.0, 2.7 |
| WSPP-2 | 30 | 25.0 | NA | 17.3, 5.0, 2.7 |
a
Abbreviations: As, arsenate resistance; Bla production; C, cadmium resistance; E, erythromycin resistance; Mup, mupirocin resistance; NA, not applicable; ND, not determined; Tp, trimethoprim resistance.